Literature DB >> 8320427

GHRH-induced GH responses during recombinant GH treatment in patients with short stature.

A Sartorio, A Spada, A Conti, M Monzani, G Faglia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320427     DOI: 10.1007/BF03348857

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  Effect of a long-term methionyl growth hormone treatment on growth hormone releasing hormone-induced growth hormone secretion in patients with constitutional growth delay.

Authors:  A Sartorio; A Conti; F Morabito; G Faglia
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.

Authors:  S M Rosenthal; J A Hulse; S L Kaplan; M M Grumbach
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH.

Authors:  J M Nakamoto; J M Gertner; C M Press; R L Hintz; R G Rosenfeld; M Genel
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

4.  Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone.

Authors:  I Gil-Ad; B Klinger; A Pertzelan; B Erster; A Silbergeld; H Talpaz; Z Laron
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

5.  Short-term met-hGH infusion inhibits somatotroph response to growth hormone releasing hormone (1-44).

Authors:  M Rosenbaum; S Loche; S Balzano; J M Gertner
Journal:  Metabolism       Date:  1988-02       Impact factor: 8.694

  5 in total
  1 in total

1.  Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.

Authors:  A Sartorio; A Conti; M Monzani; G Faglia
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.